The 20 Best Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Doctors Near Me in Michigan, US

Find the Top Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Experts and Specialists

Last Updated: 04/28/2026

Save doctors for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Already have a doctor?
Find A Second Opinion

MediFind found 151 doctor with experience in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) near Michigan, US. Of these, 123 are Experienced, 19 are Advanced and 9 are Distinguished.

Location
LocationClose
151 providers found
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine | Radiology
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine | Radiology

    U Of M Radiology Nuclear Medicine

    1500 E Medical Center Dr, Spc 5000, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    Richard Brown is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Brown is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Neuroendocrine Tumor, Mantle Cell Lymphoma (MCL), and Melorheostosis. Dr. Brown is board certified in Diagnostic Radiology, Nuclear Medicine, and Nuclear Radiology.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Neuroradiology | Radiology
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Neuroradiology | Radiology

    U Of M Radiology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    Dr. Srinivasan went to medical school in Chennai, India and pursued radiology residency at the All India Institute Medical Sciences in New Delhi. Subsequently, he did a Neuroradiology fellowship at the University of Ottawa in Canada and then joined as faculty at the University of Michigan in Ann Arbor, USA. He is presently Director of the Neuroradiology division and Associate Professor of Radiology at the University of Michigan. He received the RSNA research scholar award from 2008-2010 for his project titled ‘Creation of prediction model for response to chemoradiation in head and neck squamous cell carcinoma’. He has published over 60 papers, written 8 book chapters and presented over 90 scientific or educational presentations at national and international conferences. He is a frequent speaker at national radiology and neuroradiology conferences in the US including the American Roentgen Ray Society and the American society of Head and Neck Radiology. He presently serves on the editorial board on the Head and neck section of two premier radiology journals “Radiology” and “European Radiology”. Dr. Srinivasan is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Stroke, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Synovial Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Thrombectomy.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Neuroradiology
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Neuroradiology

    U Of M Radiology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    Gaurang Shah is a Radiologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Stroke, Sciatica, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Relapsing Multiple Sclerosis (RMS). Dr. Shah is board certified in Diagnostic Radiology and Neuroradiology.

    Learn about our expert tiers
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Cardiology | Internal Medicine
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Cardiology | Internal Medicine

    U Of M Cardiology

    24 Frank Lloyd Wright Dr, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    Dr. Yamada has been practicing medicine and cardiology for over 20 years. She has expertise in echocardiography which has allowed her to better understand, diagnose and treat cardiac disease. Her clinical and research interests include: cardiology oncology and the relationship between cancer treatment and heart disease; the role of echocardiography in understanding different cardiac pathologies and treatments; mitral valve disease; atrial fibrillation and general cardiology. Dr. Yamada launched the Cardio-Oncology clinic at the UMHS Cardiovascular Center in 2011, after a period of training at the MD Anderson Cancer Center. In this clinic, she evaluates patients who have cancer and are either at risk, or have developed cardiac disease as a complication of cancer treatment. Her goal in this clinic is to prevent, early diagnose and treat cardiac toxicity from cancer treatment, and to optimize underlying heart condition prior to cancer therapy. Dr. Yamada is also interested in helping childhood cancer survivors prevent heart complications from cancer treatment. Dr. Yamada is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Arrhythmias, and Doxorubicin-Induced Cardiomyopathy. Dr. Yamada is board certified in Cardiovascular Disease.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    U Of M Radiology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    Anil Attili is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Attili is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adrenal Cancer, Lung Nodules, Rhabdomyosarcoma Embryonal, and Cardiac Ablation.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    Northville Health Center

    39901 Traditions Dr Ste 210, 
    Northville,, MI 
    Languages Spoken:
    English

    Michael Lehmann is a Cardiologist practicing medicine in Northville,, Michigan. Dr. Lehmann is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Familial Ventricular Tachycardia, Arrhythmias, Necrosis, and Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Oncology | Hematology | Internal Medicine
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Oncology | Hematology | Internal Medicine

    Rogel Cancer Center

    1500 E Medical Center Dr, Floor B1 Reception A, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology

    Northville Health Center

    39901 Traditions Dr, Floor 2, 
    Northville, MI 
    Languages Spoken:
    English
    Offers Telehealth

    Dahlia Sano is a Hematologist practicing medicine in Northville, Michigan. Dr. Sano is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Bone Marrow Aspiration. Dr. Sano is board certified in Internal Medicine, Hematology, and Medical Oncology.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Oncology | Hematology | Hematology Oncology
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Oncology | Hematology | Hematology Oncology

    The Cancer & Hematology Centers

    710 Kenmoor Avenue Southeast, Suite 200, 
    Grand Rapids, MI 
    Experience:
    15+ years
    Languages Spoken:
    English
    Accepting New Patients

    Erin Pettijohn is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 15 years. Dr. Pettijohn is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Pettijohn is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Pettijohn is currently accepting new patients.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pathology | Hematology
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Pathology | Hematology

    U Of M Pathology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Nuclear Medicine
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiology | Nuclear Medicine

    University Hospital

    1500 E Medical Center Dr, Floor B1 Reception C, 
    Ann Arbor, MI 
    Experience:
    17+ years
    Languages Spoken:
    English

    Benjamin Viglianti is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 17 years. Dr. Viglianti is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Osteopenia, Melorheostosis with Osteopoikilosis, and Melorheostosis. Dr. Viglianti is board certified in Diagnostic Radiology and Nuclear Medicine.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Hematology Oncology
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Hematology Oncology

    Corewell Health Grand Rapids Hospitals Hematology Oncology - Lemmen-Holton

    145 Michigan Street Northeast, Suite 5200, 
    Grand Rapids, MI 
    Experience:
    18+ years
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Mohammad Alhyari is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 18 years. Dr. Alhyari is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Chronic Lymphocytic Leukemia (CLL), Pleuropulmonary Blastoma, and Lung Cancer. Dr. Alhyari is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Alhyari is currently accepting new patients.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology Oncology
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology Oncology

    The Cancer & Hematology Centers

    145 Michigan Street Northeast, Suite 3100, 
    Grand Rapids, MI 
    Experience:
    26+ years
    Languages Spoken:
    English
    Accepting New Patients

    Brett Brinker is a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 26 years. Dr. Brinker is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 60 other conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Brinker is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brinker is currently accepting new patients.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    Corewell Health Lakeland Hospitals Cancer Care Specialists Royalton

    3900 Hollywood Road, 
    Saint Joseph, MI 
    Experience:
    34+ years
    Languages Spoken:
    English
    Accepting New Patients

    Edmund Paloyan is an Oncologist practicing medicine in Saint Joseph, Michigan. He has been practicing medicine for over 34 years. Dr. Paloyan is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 76 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Breast Cancer, and Lynch Syndrome. Dr. Paloyan is board certified in American Board Of Internal Medicine. Dr. Paloyan is currently accepting new patients.

    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

    Henry Ford Cancer-Detroit

    2800 W Grand Blvd, 
    Detroit, MI 
    Languages Spoken:
    English
    Offers Telehealth

    Sheela Tejwani is an Oncologist practicing medicine in Detroit, Michigan. Dr. Tejwani is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Ganglioneuroblastoma, and Bone Marrow Aspiration.

    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology
    Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology

    Premier Hematology Oncology Care

    1701 South Boulevard East, Suite B75, 
    Rochester Hills, MI 
    Experience:
    26+ years
    Languages Spoken:
    English
    Accepting New Patients

    Savitha Kadakol is a Hematologist and an Oncologist practicing medicine in Rochester Hills, Michigan. She has been practicing medicine for over 26 years. Dr. Kadakol is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Kadakol is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Kadakol is currently accepting new patients.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Hematology | Oncology

    Corewell Health Medical Oncology Program - Lemmen-Holton

    145 Michigan Street Northeast, Suite 5200, 
    Grand Rapids, MI 
    Experience:
    22+ years
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Stephanie Dublis is a Hematologist and an Oncologist practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 22 years. Dr. Dublis is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Bone Marrow Aspiration. Dr. Dublis is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Dublis is currently accepting new patients.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiation Oncology
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Radiation Oncology

    Corewell Health William Beaumont University Hospital - Radiation Oncology

    3577 West 13 Mile Road, 
    Royal Oak, MI 
    Experience:
    16+ years
    Languages Spoken:
    English
    Accepting New Patients

    Rohan Deraniyagala is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 16 years. Dr. Deraniyagala is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Nasopharyngeal Carcinoma, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Deraniyagala is board certified in American Board Of Radiology. Dr. Deraniyagala is currently accepting new patients.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Palliative Medicine | Oncology
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Palliative Medicine | Oncology

    Cancer & Leukemia Center

    44344 Dequindre Road, Suite 260, 
    Sterling Heights, MI 
    Experience:
    41+ years
    Languages Spoken:
    English, Urdu
    Accepting New Patients
    Offers Telehealth

    Adil Akhtar is a Palliative Medicine specialist and an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 41 years. Dr. Akhtar is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Lung Adenocarcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Akhtar is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Akhtar is currently accepting new patients.

    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine
    Experienced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
    Nuclear Medicine

    Corewell Health Beaumont Troy Hospital Nuclear Medicine

    44201 Dequindre Road, 
    Troy, MI 
    Languages Spoken:
    English, Bulgarian, Macedonian, Russian
    Accepting New Patients

    Georgi Todorov is a Nuclear Medicine provider practicing medicine in Troy, Michigan. Dr. Todorov is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Osteopenia, Melorheostosis, Melorheostosis with Osteopoikilosis, and Classical Hodgkin Lymphoma. Dr. Todorov is board certified in American Board Of Nuclear Medicine. Dr. Todorov is currently accepting new patients.

    Showing 1-20 of 151

    Last Updated: 04/28/2026

    When should I see a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor in Michigan, US?

    There are various reasons why you may want to see a specialist, such as: 

    • Your primary care provider recommends it. 
    • Your condition requires expert knowledge and specialized care. 
    • Your symptoms persist or worsen despite treatment. 
    • You need specialized testing or procedures. 
    • You want a second opinion.  

    What should I consider when choosing a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor in Michigan, US?

    It’s important to see a provider with expertise in your specific condition. Each provider profile in MediFind’s doctor database includes information on which conditions they treat, years of experience, research contributions, languages spoken, insurance plans accepted, and more.  

    How does MediFind rank Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctors in Michigan, US?

    MediFind’s rankings are based on a variety of data sources, such as the number of articles a doctor has published in medical journals, participation in clinical trials and industry conferences, as well as the number of patients that provider sees for a given condition. Note that MediFind’s provider database is not based on user reviews, and providers do not pay to be included in the database. 

    What types of insurance are accepted by Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctors in Michigan, US?

    Most profiles in MediFind’s doctor database include a list of insurance plans accepted by that provider. However, it’s a good idea to contact the provider’s office to make sure they still accept your insurance, then doublecheck by contacting your insurance plan to confirm they’re in network. 

    How can I book an appointment online with a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor in Michigan, US?

    MediFind offers direct scheduling for certain providers using the “Request Appointment” button on that provider’s profile. If the schedule option is not available for a provider, tap the red “Show Phone Number” button on their profile to get their contact information. If you prefer to find providers who offer online scheduling, select “Schedules online” under the “Availability” category of the filter feature on the left side of the Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor search results page. 

    Why is it important to get a second opinion from a different Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor?

    Second opinions are an opportunity to confirm a diagnosis and its root cause, learn about alternative treatment options, or simply gain peace of mind. Many people, especially those with serious diagnoses, get second opinions so they can understand all their options and make informed decisions, so don’t hesitate to get one if you have any doubts or need more information or clarification regarding your care. Note that some insurance plans require second opinions, while others don’t cover second opinions, so be sure to confirm with your insurance provider first.   

    How can I prepare for my appointment with a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor in Michigan, US?

    Prepare for your appointment by gathering the following items: 

    • Copies of medical records (dating back at least one year) 
    • Your medical history, including illnesses, medical conditions, surgeries, and other doctors you see 
    • Family history of disease 
    • List of current prescription drugs, over-the-counter medicines, vitamins, and herbal remedies or supplements including names and doses 
    • Allergies to medications, food, latex, insects, etc.  
    • List of questions and concerns 
    • Your insurance card 

    You might also contact the provider’s office to see if they offer transportation or childcare services or if you’re allowed to bring a loved one for support or to take notes during your visit. 

    What questions should I ask my Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor?

    Here are some sample questions: 

    • Can you explain in simple terms what this condition is and how it’s treated? 
    • What symptoms or side effects should I watch for? 
    • What tests will be involved, and when can I expect results? 
    • Are there other specialists I need to see? 
    • What’s the best way to reach you if I have follow-up questions? 

    How can I learn about the latest clinical trials and research advances my Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor may know about?

    MediFind’s Clinical Trials tool asks you a series of questions to help you narrow down your search by health condition, age, gender, location, how far you’re willing to travel, and more. Each question you answer filters down the number of trials until you find the ones that are most relevant to you. 

    MediFind’s Latest Advances tool features summaries of recent articles published in medical journals. We use cutting-edge technology to scour medical publication databases for the latest research advancements on any given condition, then we simplify this information in a way that’s useful and easy to understand. 

    Can I filter my search to show male or female Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctors in Michigan, US?

    Look for the filter feature on the left side of the Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor search results page. Select “Female” or “Male” under the “Gender” category to search for female or male providers exclusively. If the “Any” option is selected, it will pull results for both male and female providers. 

    Can I filter my search to find a Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor that offers video calls?

    Look for the filter feature on the left-side of the Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) doctor search results page. Select “Offers telehealth visits” under the Availability category to search for providers who offer virtual appointments (video calls). 

    Reviewed on: 11/11/24  

    By: MediFind Medical Staff 

    Read more about our Content Policy

    More Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Doctors by city